Atlas Trials

Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography

Clinical trial NCT04338165 · UNKNOWN

Trial details

NCT number
NCT04338165
Sponsor
University Hospital, Grenoble
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Atherosclerotic Cardiovascular Disease
Start date
2021-01-08
Primary completion
2022-11-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.